Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Immunocore Holdings Community
NasdaqGS:IMCR Community
1
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Create a narrative
Immunocore Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
Immunocore Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
AI Tools And Global Expansion Will Broaden KIMMTRAK's Market Reach
Key Takeaways Expansion into less dense U.S. markets and international launches are key to driving revenue growth for Immunocore's KIMMTRAK. Strong financial position and diverse clinical pipeline position Immunocore for future revenue growth and increased net margins.
View narrative
US$62.75
FV
54.7% undervalued
intrinsic discount
12.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
9 days ago
author updated this narrative
Your Valuation for
IMCR
IMCR
Immunocore Holdings
Your Fair Value
US$
Current Price
US$28.40
33.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-156m
748m
2015
2018
2021
2024
2025
2027
2030
Revenue US$747.9m
Earnings US$152.6m
Advanced
Set Fair Value